Mesenchymal Stem Cells for the Treatment of COVID-19

Summary

This double blind, placebo controlled, multi-arm, multi-site study investigates the safety and efficacy of stem cell therapy for the treatment of patients admitted to hospital suffering complications from COVID-19 and the treatment of healthy subjects (healthcare providers) for prophylactic effect following those patients.

Timeline

Start

2020-04-24

Primary completion

2020-08-20

Completion

2020-09-01

Drugs

Indications